DLTH:NASDAQDuluth Holdings Inc. Analysis
Data as of 2026-03-29 - not real-time
$3.01
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Duluth Holdings is trading well below its discounted cash‑flow estimate, suggesting a sizable margin of safety for value‑oriented investors. The stock’s RSI sits in the upper‑mid range and the MACD shows a bullish signal, indicating short‑term momentum is still positive despite a neutral overall trend. Beta above one and 30‑day volatility exceeding a hundred percent point to pronounced price swings, which amplifies both upside potential and downside risk. The company’s balance sheet is strained, with debt levels far outpacing cash and a negative earnings profile, yet operating cash flow remains positive and free cash flow is modestly healthy. Recent earnings releases highlighted a turnaround in quarterly profit per share, beating consensus estimates and delivering an improved gross margin above 50%, which provides a glimpse of operational improvement. However, the negative profit margin and ROE underscore lingering profitability challenges. The market’s “greed” sentiment index is in the optimistic range, but the high implied upside of over 60% relative to the current price may already be priced in by speculative traders. With support comfortably above the current level and resistance still above recent highs, the price has room to climb if momentum sustains. Investors should weigh the attractive valuation against the elevated volatility and leverage.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD but neutral trend
- High volatility and beta
- Current price near support
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation upside vs DCF
- Improving quarterly earnings and margins
- Positive operating cash flow
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Persistent debt burden
- Cyclical consumer sector exposure
- Uncertain profitability trajectory
Key Metrics & Analysis
Financial Health
Revenue Growth-10.50%
Profit Margin-2.90%
P/E Ratio-33.4
ROE-9.40%
ROA-1.31%
Debt/Equity88.75
P/B Ratio0.7
Op. Cash Flow$24.2M
Free Cash Flow$22.6M
Technical Analysis
TrendNeutral
RSI65.9
Support$2.04
Resistance$3.34
MA 20$2.52
MA 50$2.42
MA 200$2.63
MACDBullish
VolumeIncreasing
Fear & Greed Index65.98
Valuation
Fair Value$4.60
Target Price$5.00
Upside/Downside66.11%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.62
Volatility119.73%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.